-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, an authoritative journal in the field of neurology published a research article in Neurology, which aims to clarify the serum S100B protein concentration as an objective biomarker of astrocyte tissue damage after mechanical thrombus removal in patients with acute ischemic stroke .
Stroke
This prospective two-center study recruited patients with acute middle cerebral artery infarction who were treated with mechanical thrombus removal due to large vessel occlusion
Blood vessel
The study included a total of 171 patients (mean age ± SD: 70 ± 14 years, 42% were women)
Younger age (OR 1.
It can be seen that the serum concentration of S100B after mechanical thrombus removal can reflect the degree of ischemic tissue damage
S100B serum concentration after mechanical thrombus removal can reflect the degree of ischemic tissue damage
Original source:
Sebastian Luger.
Role of S100B Serum Concentration as a Surrogate Outcome Parameter After Mechanical Thrombectomy
in this message